Application 215593
- Type
- ANDA
- Sponsor
- CIVICA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPHEDRINE SULFATE | EPHEDRINE SULFATE | SOLUTION;INTRAVENOUS | 50MG/ML (50MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215593-001 | EPHEDRINE SULFATE | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2025-12-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A215593-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2025-12-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215593-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2025-12-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215593-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2025-12-23 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215593-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | 2025-12-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215593-001 | AP | 1 | 011fe1cb6892… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ephedrine sulfate | EPHEDRINE SULFATE | Medical Purchasing Solutions, LLC | 08f5ec19-7b53-681b-e063-6294a90acc86 | 2023-10-30 | Warnings, Adverse reactions | Ephedrine sulfate EPHEDRINE SULFATE |
| Ephedrine sulfate | EPHEDRINE SULFATE | Dr. Reddy's Laboratories, Inc. | 1d1c41c1-8f5f-ee76-c890-4f1f2a3b2e96 | 2023-08-01 | Warnings, Adverse reactions | Ephedrine sulfate EPHEDRINE SULFATE |
| EPHEDRINE SULFATE | EPHEDRINE SULFATE | Par Health USA, LLC | a247857e-ba7b-4a37-b132-4ba9b0d1c4d1 | 2023-05-31 | Warnings, Adverse reactions | EPHEDRINE SULFATE EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Medical Purchasing Solutions, LLC | d163ff39-d1a4-b61f-e053-2995a90ab6d5 | 2023-05-02 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Medical Purchasing Solutions, LLC | c8e8ec0e-988b-85a1-e053-2a95a90a2268 | 2023-04-25 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Xiromed, LLC | 8302176c-d443-97f1-1a49-12b9a204121a | 2023-04-11 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Civica, Inc. | 8f6c6588-77b6-40c7-a897-52e881854d7f | 2023-03-31 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Sagent Pharmaceuticals | 614e6649-a0e1-4428-855b-363abdb126d8 | 2023-03-03 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| ephedrine sulfate | EPHEDRINE SULFATE | Baxter Healthcare Corporation | 552c341b-4892-4dc7-8b9f-cb6be914b0d1 | 2023-01-20 | Warnings, Adverse reactions | ephedrine sulfate EPHEDRINE SULFATE |
| Emerphed | EPHEDRINE SULFATE | Nexus Pharamaceuticals Inc. | e1323592-dc57-4c9d-b84d-442648a7b114 | 2022-09-30 | Warnings, Adverse reactions | EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Fresenius Kabi USA, LLC | 5ecd9746-25c7-4bd4-9503-eb97e7db5aa5 | 2022-08-24 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| EPHEDRINE SULFATE | EPHEDRINE SULFATE | Par Health USA, LLC | 2c203482-8a04-40fc-93d2-74b30dec7742 | 2022-04-30 | Warnings, Adverse reactions | EPHEDRINE SULFATE EPHEDRINE SULFATE |
| Ephedrine sulfate | EPHEDRINE SULFATE | Lifestar Pharma LLC | 49fc67d1-3b30-456b-951c-ca7f703432ab | 2022-04-22 | Warnings, Adverse reactions | Ephedrine sulfate EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Gland Pharma Limited | 4a66e6c1-6d01-46fa-a2da-566fbf6e11a4 | 2022-03-04 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
| Akovaz | EPHEDRINE SULFATE | Exela Pharma Sciences, LLC | e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9 | 2020-11-27 | Warnings, Adverse reactions | EPHEDRINE SULFATE |
| Ephedrine Sulfate | EPHEDRINE SULFATE | Sandoz Inc | c8af7bb5-41da-4f8c-8acd-f489892a0d72 | 2020-05-20 | Warnings, Adverse reactions | Ephedrine Sulfate EPHEDRINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.